Related Experiment Video
Updated: Mar 19, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Evaluation of antibiotic use in Pediatric Intensive Care Unit of a developing country
Qalab Abbas1, Anwar Ul Haq1, Raman Kumar1
1Department of Pediatric and Child Health, Aga Khan University, Karachi, Sindh, Pakistan.
Insights
Antibiotic use is universal in Pediatric Intensive Care Units (PICUs), with most patients receiving multiple drugs. Strategies are needed to optimize antibiotic prescribing and combat antimicrobial resistance.
Area of Science:
- Pediatric Intensive Care
- Antimicrobial Stewardship
- Infectious Diseases
Background:
- Pediatric Intensive Care Unit (PICU) patients often receive antibiotics at a higher threshold than other patient populations.
- Irrational antibiotic use accelerates the development of antimicrobial resistance, necessitating surveillance of prescribing patterns.
Purpose of the Study:
- To evaluate antibiotic utilization in a tertiary hospital's PICU.
- To correlate antibiotic use with bacteriological findings.
Main Methods:
- A retrospective review of medical records for children (1 month-16 years) admitted to a multidisciplinary-cardiothoracic PICU from January to June 2013.
- Antibiotic indications (prophylactic, empiric, therapeutic) and duration were recorded.
- Infection diagnoses followed the 2005 International Pediatric Sepsis Consensus Conference (IPSCC) criteria.
Main Results:
- All 240 PICU patients received antibiotics; 43% prophylactically, 42% empirically, and 15% therapeutically.
- The median number of antibiotics per patient was 3 (range 1-7), with 29% receiving 3 antibiotics.
- Commonly used antibiotics included cefazolin, meropenem, vancomycin, and ceftriaxone; meropenem and vancomycin were the most frequent combination.
Conclusions:
- This study is the first to report on antibiotic use in a PICU in the specified country, revealing universal prescription.
- There is a critical need for strategies to better assess and manage antibiotic requirements in the PICU setting.
Background:
Pediatric Intensive Care Unit (PICU) patients are often prescribed antibiotics with a low threshold in comparison to patients elsewhere. Irrational antibiotics use can lead to rapid emergence of drug resistance, so surveillance of their use is important.
Objectives:
To evaluate the use of antibiotics in relation to bacteriological findings in PICU of a Tertiary Hospital.
Methods:
Retrospective review of medical records of all children (age 1 month-16 years) admitted in our closed multidisciplinary-cardiothoracic PICU from January to June 2013 was performed, after approval from Ethical Review Committee. For each antibiotic, indication (prophylactic, empiric, therapeutic) and duration of use were recorded. All diagnoses of infections were recorded according to diagnostic criteria of IPSCC 2005. Results are presented as frequency and percentages and median with inter quartile range using SPSS version 19.
Results:
All of the total 240 patients admitted in PICU during the study period received antibiotics: 43% (n = 104) prophylactically, 42% (n = 102) empirically, and 15% (n = 15) therapeutically. Median number of antibiotic use per patient in PICU was 3, with range of 1-7. 25% received 1 antibiotic, 23% received 2 antibiotics, 29% received 3 antibiotics, and rest received ≥4 antibiotics. Most commonly used antibiotics were cefazolin, meropenem, vancomycin and ceftriaxone, and most frequently used combination was meropenem and vancomycin. In majority of the cases, (70%) empiric antibiotic combinations were stopped in 72 h.
Conclusion:
This is the first report of antibiotics use in PICU from our country, which shows that antibiotics are prescribed universally in our PICU. Strategies to assess the need for antibiotic use are needed.
More Related Videos
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Urine Studies II: Urine Culture and Sensitivity Test
Clinical Significance of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management
Antibiotic Selection
Antimicrobial Effectiveness